Method for diagnosing esophageal cancer

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007210, C435S091200, C435S091210, C435S091510, C536S023500

Reexamination Certificate

active

07932032

ABSTRACT:
This invention relates to a composition, kit, or DNA chip comprising polynucleotides and antibodies as probes for detecting, determining, or predicting the presence or metastasis of esophageal cancer, and to a method for detecting, determining, or predicting the presence or metastasis of esophageal cancer using the same.

REFERENCES:
patent: 5990299 (1999-11-01), Ruzdijic et al.
patent: 2003/0073105 (2003-04-01), Lasek et al.
patent: 2009/0270267 (2009-10-01), Akiyama et al.
patent: WO-01/74405 (2001-10-01), None
patent: WO-01/94629 (2001-12-01), None
patent: WO-2004/048938 (2004-06-01), None
patent: WO-2005/031001 (2005-04-01), None
Tomatsu et al. Journal Inherited Metabolism Disease. 1994. 17: 601-605.
National Center For Biotechnology Information, National Library of Medicine, NIH (Bethesda, MD, USA) GenBank Accession No. NM—000512, Mar. 23, 2005.
Coleman. Drug Discovery Today. 2003. 8: 233-235.
Liu et al. Clinical Immunology. 2004. 112: 225-230.
Saetre et al. Molecular Brain Research. 2004. 126: 198-206.
GeneCard for GALNS, available via url: <genecards.org/cgi-bin/carddisp.pl?gene=GALNS>, printed Jun. 29, 2010.
Dahlberg et al. Ann Thorac Surg. 2004. 77: 1008-1015.
Kimos et al., “Esophagin and proliferating cell nuclear antigen (PCNA) are biomarkers of human esophageal neoplastic progression,” Int. J. Cancer, 2004, vol. 111, No. 3, pp. 415-417.
Nemoto T et al.; “Overexpression of Protein Tyrosine Kinases in Human Esophageal Cancer”, Pathobiology, 1997, vol. 65, pp. 195-203, XP009048170.
Ginkel et al., “Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival,” Cancer Res., 2004, vol. 64, No. 1, pp. 128-134.
Su et al., “Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer,” Cancer Res., 2003, vol. 63, No. 14, pp. 3872-3876.
Ebihara et al., “DARPP-32 expression arises after a phase of dysplasia in oesophageal squamous cell carcinoma,” Br.J. Cancer, 2004, vol. 91, No. 1, pp. 119-123.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for diagnosing esophageal cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for diagnosing esophageal cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for diagnosing esophageal cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2657693

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.